Study identification

PURI

https://redirect.ema.europa.eu/resource/44366

EU PAS number

EUPAS44365

Study ID

44366

Official title and acronym

Biopsychosocial characteristics of patients with fibromyalgia / chronic widespread pain. A cross-sectional review of depersonalized data from the German Pain e-Registry. (F-type Pain)

DARWIN EU® study

No

Study countries

Germany

Study description

Fibromyalgia (FM), respective the chronic widespread pain syndrome (CWSP) is a medical condition characterized by chronic widespread pain and a heightened pain response to pressure. Other symptoms include tiredness to a degree that normal activities are affected, sleep problems, and cognitive dysfunctions. Some people also report restless legs syndrome, bowel or bladder problems, numbness and tingling and sensitivity to noise, lights or temperature. Patients with fibromyalgia are more likely to suffer from depression, anxiety and posttraumatic stress disorder. To gain further insight into the prevalence and biopsychosocial consequences of FM in patients we evaluated anonymized real-world data derived from routine medical care in pain centers within the German Pain e-Registry (GPeR), a national web-based registry developed in cooperation with the German Pain Association (Deutsche Gesellschaft für Schmerzmedizin) and the German Pain League (Deutsche Schmerzliga).

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Michael Ueberall

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

German Pain Association, IFNAP - private Institute of Neurological Sciences
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable